FDA offers guidance on financial disclosures under Sunshine Act

03/7/2013 | MassDevice.com (Boston)

The FDA has issued draft guidance governing financial disclosures mandated by the Sunshine Act, which will go into effect Aug. 1. The document explains how manufacturers should report financial ties with doctors when applying for FDA marketing approval, which of those relationships should be reported and how bias is established.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC